Clomipramine Impurity 18 | CAS 59691-00-8 - Request Quote
Clomipramine Impurity 18
| SZ CAT No: | SZ-C012046 |
| CAS No | 59691-00-8 |
| Mol.F. | C14H10ClN |
| Mol.Wt. | 227.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Clomipramine Impurity 18 is chemically 10-Chloro-5H-dibenzo[b,f]azepine. Clomipramine Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Clomipramine Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clomipramine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 59691-00-8
Purchase 59691-00-8
Order 59691-00-8
Enquire 59691-00-8
price of 59691-00-8
59691-00-8 Supplier
59691-00-8 Manufacturer
59691-00-8 Exporter
buy high quality Clomipramine Impurity 18
Purchase Clomipramine Impurity 18
Clomipramine Impurity 18 suppliers
Clomipramine Impurity 18 manufacturers
Clomipramine Impurity 18 price
Order Clomipramine Impurity 18
Enquire Clomipramine Impurity 18
Clomipramine Impurity 18 cost
Clomipramine Impurity 18 Supplier
Clomipramine Impurity 18 Distributor
Clomipramine Impurity 18 for Method Validation
Clomipramine Reference Standard
Clomipramine Impurity 18 for ANDA Filing
Clomipramine Impurity 18 for Forced Degradation Studies
Clomipramine Impurity 18 Identification Standards
Clomipramine Impurity 18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


